Cargando…

Recombinant activated factor VII in a patient with intracranial hemorrhage and severe thrombocytopenia

Hemorrhage in patients with hematologic malignancies is often difficult to manage as many of these patients also have coagulopathy and thrombocytopenia of varying severity. Recombinant factor VIIa is a FDA‐approved agent for management of bleeding in hemophilia patients with inhibitors. Use of recom...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansari, Amir M., Khorasanchi, Adam, Faghihimehr, Armaghan, Toor, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502438/
https://www.ncbi.nlm.nih.gov/pubmed/34659753
http://dx.doi.org/10.1002/ccr3.4788